|
Volumn 297, Issue 2, 2001, Pages 606-611
|
RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
LISINOPRIL;
RXP 407;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BLOOD PRESSURE REGULATION;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG INHIBITION;
DRUG METABOLISM;
ENZYME ACTIVE SITE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN DOMAIN;
|
EID: 0035042245
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (101)
|
References (24)
|